Viridian Therapeutics, Inc.VRDNNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-471.90%
↑ 97% vs avg
Percentile
P54
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-17950.59%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -471.90% | +99.5% |
| 2024 | -87967.88% | -17.4% |
| 2023 | -74957.01% | -928.6% |
| 2022 | -7287.42% | -172.3% |
| 2021 | -2676.00% | +30.2% |
| 2020 | -3836.19% | -320.0% |
| 2019 | -913.47% | -142.8% |
| 2018 | -376.21% | +41.7% |
| 2017 | -645.04% | -72.1% |
| 2016 | -374.83% | - |